Page last updated: 2024-11-05

vesnarinone and Pancreatic Neoplasms

vesnarinone has been researched along with Pancreatic Neoplasms in 1 studies

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nio, Y1
Ohmori, H1
Minari, Y1
Hirahara, N1
Sasaki, S1
Takamura, M1
Tamura, K1

Other Studies

1 other study available for vesnarinone and Pancreatic Neoplasms

ArticleYear
A quinolinone derivative, vesnarinone (OPC-8212), significantly inhibits the in vitro and in vivo growth of human pancreatic cancer cell lines.
    Anti-cancer drugs, 1997, Volume: 8, Issue:7

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Cell Survival; Collagen; Drug Combina

1997